Vasilyeva Olga N, Frisina Susan T, Zhu Xiaoxia, Walton Joseph P, Frisina Robert D
Otolaryngology Department, University of Rochester Medical School & Dentistry, 601 Elmwood Ave., Rochester, NY 14642-8629, USA.
Hear Res. 2009 Mar;249(1-2):44-53. doi: 10.1016/j.heares.2009.01.007.
Recently, we characterized the more severe nature of hearing loss in aged Type 2 diabetic human subjects [Frisina, S.T., Mapes, F., Kim, S., Frisina, D.R., Frisina, R.D., 2006. Characterization of hearing loss in aged type II diabetics. Hear. Res. 211, 103-113]. The current study prospectively assessed hearing abilities in middle age CBA/CaJ mice with Type 1 diabetes mellitus (T1DM) (STZ injection) or Type 2 diabetes mellitus (T2DM) (high fat diet), for a period of 6 months. Blood glucose, body weight and auditory tests (Auditory Brainstem Response-ABR, Distortion Product Otoacoustic Emissions-DPOAE) were evaluated at baseline and every 2 months. Tone and broad-band noise-burst responses in the inferior colliculus were obtained at 6 months. Body weights of controls did not change over 6 months (approximately 32 g), but there was a significant (approximately 5 g) decline in the T1DM, while T2DM exhibited approximately 10 g weight gain. Blood glucose levels significantly increased: 3-fold for T1DM, 1.3-fold for T2DM; with no significant changes in controls. ABR threshold elevations were found for both types of diabetes, but were most pronounced in the T2DM, starting as early as 2 months after induction of diabetes. A decline of mean DPOAE amplitudes was observed in both diabetic groups at high frequencies, and for the T2DM at low frequencies. In contrast to ABR thresholds, tone and noise thresholds in the inferior colliculus were lower for both diabetic groups. Induction of diabetes in middle-aged CBA/CaJ mice promotes amplification of age-related peripheral hearing loss which makes it a suitable model for studying the interaction of age-related hearing loss and diabetes. On the other hand, initial results of effects from very high blood glucose level (T1DM) on the auditory midbrain showed disruption of central inhibition, increased response synchrony or enhanced excitation in the inferior colliculus.
最近,我们对老年2型糖尿病患者听力损失的更严重性质进行了特征描述[弗里西纳,S.T.,梅普斯,F.,金,S.,弗里西纳,D.R.,弗里西纳,R.D.,2006年。老年2型糖尿病患者听力损失的特征描述。《听力研究》211,103 - 113]。当前研究前瞻性地评估了患有1型糖尿病(T1DM)(注射链脲佐菌素)或2型糖尿病(T2DM)(高脂饮食)的中年CBA/CaJ小鼠的听力能力,为期6个月。在基线以及每2个月时评估血糖、体重和听力测试(听性脑干反应 - ABR、畸变产物耳声发射 - DPOAE)。在6个月时获取下丘的纯音和宽带噪声脉冲反应。对照组的体重在6个月内没有变化(约32克),但T1DM组体重显著下降(约5克),而T2DM组体重增加约10克。血糖水平显著升高:T1DM组升高3倍,T2DM组升高1.3倍;对照组无显著变化。两种类型的糖尿病均发现ABR阈值升高,但在T2DM中最为明显,早在糖尿病诱导后2个月就开始出现。在两个糖尿病组中均观察到高频时平均DPOAE振幅下降,T2DM组在低频时也出现下降。与ABR阈值相反,两个糖尿病组在下丘的纯音和噪声阈值较低。中年CBA/CaJ小鼠诱导糖尿病会促进与年龄相关的外周听力损失的加剧,这使其成为研究与年龄相关的听力损失和糖尿病相互作用的合适模型。另一方面,极高血糖水平(T1DM)对听觉中脑影响的初步结果显示下丘的中枢抑制受到破坏、反应同步性增加或兴奋增强。